Medable Introduces TeleCOA


Medable Inc., has announced Medable TeleCOA. This new offering combines electronic Clinical Outcome Assessments (eCOAs) with TeleVisits on web and mobile to enable critical study outcomes to be captured from the comfort of a patient’s home, anywhere in the world. This combination will facilitate the transition of eCOAs from clinic-only to remote and decentralized settings.

The Medable platform enables study-specific digital workflows for patients and sites for recruitment, screening, consent, and throughout study conduct. Unlike traditional eCOA point solutions that silo data and are tied to in-person visits, Medable TeleCOA allows outcome assessments to be conducted remotely via web and mobile. TeleCOA enables a fully remote live interaction between patients and clinicians for remote capture of outcome assessments by allowing a clinician to simultaneously perform the assessment while also evaluating and guiding the patient.

“As a health policy wonk by training, a clinical researcher by choice, and optic atrophy patient advocate by necessity, I believe we can learn a great deal from the patient community and incorporate patient perspectives across the clinical trial landscape to accelerate trial timelines,” said Richie Kahn, Medable PAC member. “I’m excited that Medable’s decentralized clinical trial platform and Medable TeleCOA are built with these perspectives in mind. By combining eCOA with TeleVisits on any web-enabled device, Medable has made it much easier to shift onsite visits to remote without sacrificing the most important interactions between patient and investigator.”

Read more in the full release, here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.